Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Blood flow restriction training for lateral elbow tendinopathy

Official title: Randomisierte, Kontrollierte Untersuchung Der Wirksamkeit Von Blood Flow Restriction (BFR)-Training Zur Behandlung Der Epicondylopathia Humeri Radialis

Run by Technical University of Munich · NCT07172568 · Data updated 2026-11-12

This trial will test whether adding blood flow restriction (BFR) training to usual physiotherapy helps adults with lateral epicondylopathy (tennis elbow) who have had symptoms for more than six weeks.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment40 (estimated)
SponsorTechnical University of Munich
Academic / other
Locations1 site (Munich, Bavaria)
StatusRecruiting
StartedAugust 25, 2021
Main results expectedDecember 31, 2025
Study endsFebruary 2026
Registry record updatedSeptember 15, 2025
Trial IDNCT07172568 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with a clinical diagnosis of lateral epicondylitis (tennis elbow) lasting more than six weeks who have not improved with prior physical therapy, have no concerning X-ray findings, and can give informed consent are the intended participants.

Probably not a fit

People with symptom duration over 12 months, prior joint injections, concurrent rheumatoid or other elbow/nerve pathologies, radicular symptoms, or traumatic causes are excluded and are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, controlled intervention that supplements standard exercise therapy with either true blood flow restriction (BFR) or a sham BFR procedure applied to the affected limb. BFR uses a cuff or tourniquet to partially restrict blood flow to the muscle during low-load exercise, with the aim of stimulating strength and muscle adaptations. The protocol monitors safety and compares clinical outcomes between groups over the treatment period. The study builds on prior BFR work in other orthopaedic rehabilitation settings to determine whether it provides added benefit for lateral elbow tendinopathy.

Why it matters

Potential benefit: If successful, adding BFR to physiotherapy could speed recovery, reduce muscle atrophy, and improve strength and function in people with tennis elbow compared with exercise alone.

How similar studies have gone: Systematic reviews and trials in other musculoskeletal settings have shown that BFR can reduce atrophy and increase strength, with early positive results after ACL reconstruction and distal radius fracture rehabilitation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* diagnosis of lateral epicondylitis
* duration of symptoms \> 6 weeks
* failed physical therapy
* absence of x-ray abnormalities
* written and informed consent

Exclusion Criteria:

* prior joint infiltrations
* duration of symptoms \> 12 months
* concomitant rheumatoid diseases
* concomitant elbow pathologies, including medial epicondylitis
* concomitant radicular symptoms of the cervical spine, shoulder or hand
* traumatic etiology of symptoms

Where it's running

  • Department of Sports Orthopaedics, Technical University of Munich
    Munich, Bavaria, Germany
    Recruiting

Study contacts

  • Principal investigator: Maximilian Hinz, MD — Department of Sports Orthopaedics, Technical University of Munich
  • Study coordinator: Alexandros Doucas, MD
  • Email: a.doucas@tum.de
  • Phone: +491737442245

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.